Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars
CHICAGO, Nov. 22, 2022 /PRNewswire/ -- To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity,
Source: wsiltv.com
